Praecis Pharmaceuticals INC
SEC CIK 1033025 · PRCS · last insider filing 2007-02-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sharrock David B | Director | filed 2007 - 2007 |
| Zenner Patrick J | Director | filed 2007 - 2007 |
| Baker G Leonard JR | Director | filed 2007 - 2007 |
| Mccance Henry F | Director | filed 2007 - 2007 |
| Mclaughlin Kevin F | Director · President and CEO | filed 2006 - 2007 |
| Gefter Malcolm L PHD | Director · Chairman and CSO | filed 2006 - 2007 |
| Post Leonard E | Director | filed 2007 - 2007 |
| Bohlin Garen G | Director | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wagner Richard W | EVP, Discovery Research | filed 2007 - 2007 |
| English Edward C | VP, CFO, Treasurer & Ass. Sec. | filed 2007 - 2007 |
| Garnick Marc B | EVP and Chief Medical Officer | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.